Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21757983rdf:typepubmed:Citationlld:pubmed
pubmed-article:21757983lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:21757983lifeskim:mentionsumls-concept:C0013216lld:lifeskim
pubmed-article:21757983lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:21757983lifeskim:mentionsumls-concept:C2239176lld:lifeskim
pubmed-article:21757983lifeskim:mentionsumls-concept:C1533685lld:lifeskim
pubmed-article:21757983lifeskim:mentionsumls-concept:C0221464lld:lifeskim
pubmed-article:21757983lifeskim:mentionsumls-concept:C0574032lld:lifeskim
pubmed-article:21757983lifeskim:mentionsumls-concept:C0336636lld:lifeskim
pubmed-article:21757983lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:21757983lifeskim:mentionsumls-concept:C1512948lld:lifeskim
pubmed-article:21757983lifeskim:mentionsumls-concept:C1517564lld:lifeskim
pubmed-article:21757983lifeskim:mentionsumls-concept:C1548161lld:lifeskim
pubmed-article:21757983pubmed:issue2lld:pubmed
pubmed-article:21757983pubmed:dateCreated2011-7-15lld:pubmed
pubmed-article:21757983pubmed:abstractTextCombination treatment consisting of hepatic arterial infusion chemotherapy with epirubicin and cisplatin (HAIC-EC) and systemic infusion of low-dose 5-fluorouracil (5-FU) are sometimes effective against advanced hepatocellular carcinoma (HCC). However, there is no effective treatment for advanced HCCs with arterioportal shunts (APS) or arteriovenous shunts (AVS).lld:pubmed
pubmed-article:21757983pubmed:languageenglld:pubmed
pubmed-article:21757983pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21757983pubmed:citationSubsetIMlld:pubmed
pubmed-article:21757983pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21757983pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21757983pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21757983pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21757983pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21757983pubmed:statusMEDLINElld:pubmed
pubmed-article:21757983pubmed:monthJunlld:pubmed
pubmed-article:21757983pubmed:issn1738-222Xlld:pubmed
pubmed-article:21757983pubmed:authorpubmed-author:JungGuhungGlld:pubmed
pubmed-article:21757983pubmed:authorpubmed-author:ParkYoung...lld:pubmed
pubmed-article:21757983pubmed:authorpubmed-author:ParkSang...lld:pubmed
pubmed-article:21757983pubmed:authorpubmed-author:LeeKi JongKJlld:pubmed
pubmed-article:21757983pubmed:authorpubmed-author:KimBo HyunBHlld:pubmed
pubmed-article:21757983pubmed:authorpubmed-author:KimNha...lld:pubmed
pubmed-article:21757983pubmed:authorpubmed-author:YunHan...lld:pubmed
pubmed-article:21757983pubmed:authorpubmed-author:KimJa SeonJSlld:pubmed
pubmed-article:21757983pubmed:authorpubmed-author:YeonJae WooJWlld:pubmed
pubmed-article:21757983pubmed:issnTypePrintlld:pubmed
pubmed-article:21757983pubmed:volume17lld:pubmed
pubmed-article:21757983pubmed:ownerNLMlld:pubmed
pubmed-article:21757983pubmed:authorsCompleteYlld:pubmed
pubmed-article:21757983pubmed:pagination120-9lld:pubmed
pubmed-article:21757983pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:21757983pubmed:meshHeadingpubmed-meshheading:21757983...lld:pubmed
pubmed-article:21757983pubmed:meshHeadingpubmed-meshheading:21757983...lld:pubmed
pubmed-article:21757983pubmed:meshHeadingpubmed-meshheading:21757983...lld:pubmed
pubmed-article:21757983pubmed:meshHeadingpubmed-meshheading:21757983...lld:pubmed
pubmed-article:21757983pubmed:meshHeadingpubmed-meshheading:21757983...lld:pubmed
pubmed-article:21757983pubmed:meshHeadingpubmed-meshheading:21757983...lld:pubmed
pubmed-article:21757983pubmed:meshHeadingpubmed-meshheading:21757983...lld:pubmed
pubmed-article:21757983pubmed:meshHeadingpubmed-meshheading:21757983...lld:pubmed
pubmed-article:21757983pubmed:meshHeadingpubmed-meshheading:21757983...lld:pubmed
pubmed-article:21757983pubmed:meshHeadingpubmed-meshheading:21757983...lld:pubmed
pubmed-article:21757983pubmed:meshHeadingpubmed-meshheading:21757983...lld:pubmed
pubmed-article:21757983pubmed:meshHeadingpubmed-meshheading:21757983...lld:pubmed
pubmed-article:21757983pubmed:meshHeadingpubmed-meshheading:21757983...lld:pubmed
pubmed-article:21757983pubmed:meshHeadingpubmed-meshheading:21757983...lld:pubmed
pubmed-article:21757983pubmed:meshHeadingpubmed-meshheading:21757983...lld:pubmed
pubmed-article:21757983pubmed:meshHeadingpubmed-meshheading:21757983...lld:pubmed
pubmed-article:21757983pubmed:meshHeadingpubmed-meshheading:21757983...lld:pubmed
pubmed-article:21757983pubmed:year2011lld:pubmed
pubmed-article:21757983pubmed:articleTitleCombination treatment with intrahepatic arterial infusion and intratumoral injection chemotherapy in patients with far-advanced hepatocellular carcinoma and arterioportal or arteriovenous shunts: preliminary results.lld:pubmed
pubmed-article:21757983pubmed:affiliationHepatology Center, Bundang Jesaeng General Hospital, Seongnam, Korea.lld:pubmed
pubmed-article:21757983pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21757983pubmed:publicationTypeCase Reportslld:pubmed